logo

For the Inventor, By the Inventor

Wellesley, MA, United States of America

Richard F Selden

This inventor holds 30 USPTO granted patents and 5 published patent applications and 5 EPO patents, primarily in Gene Therapy. Top assignees: Transkaryotic Therapies, Inc., Shire Human Genetic Therapies, Inc.. Active years: 1997-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard F Selden. Retrieved from https://idiyas.com/inventor/richard-f-selden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 15

Forward Citations = 899(Granted Patents)


Location History:

  • Cambridge, MA (US) (2006)
  • Wellesley, MA (US) (1997 - 2008)

Company Filing History:

goldMedal28 out of 40 
 
Transkaryotic Therapies, Inc.
 patents
silverMedal2 out of 86 
 
Shire Human Genetic Therapies, Inc.
 patents

Years Active: 1997-2008

Loading Chart...
Loading Chart...
Areas of Expertise:
Erythropoietin
Insulinotropin
Nucleic Acid
Chimeric Polypeptide
Protein Delivery
Gene Therapy
In Vivo Production
DNA Introduction
Clonal Cell Strains
Genomic Sequences
Transkaryotic Implantation
Alpha-Galactosidase A
30 patents (USPTO):Explore Patents
1. 7410799 - In vivo production and delivery of erythropoietin or insulinotropin for gene therapy (2008-08-12),
2. 7122354 - Nucleic acid encoding a chimeric polypeptide (2006-10-17),
3. 7094400 - Transkaryotic implantation (2006-08-22),
4. 6924365 - Optimized messenger RNA (2005-08-02),
5. 6846676 - In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy (2005-01-25),
6. 6692737 - In vivo protein production and delivery system for gene therapy (2004-02-17),
7. 6670178 - In Vivo production and delivery of insulinotropin for gene therapy (2003-12-30),
8. 6566099 - Nucleic acid encoding a chimeric polypeptide (2003-05-20),
9. 6565844 - Protein production and protein delivery (2003-05-20),
10. 6537542 - Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production (2003-03-25),
11. 6531124 - In vivo production and delivery of insulinotropin for gene therapy (2003-03-11),
12. 6458574 - Treatment of a &agr;-galactosidase a deficiency (2002-10-01),
13. 6395884 - Therapy for &agr;-galactosidase a deficiency (2002-05-28),
14. 6355241 - In vivo production and delivery of erythropoietin (2002-03-12),
15. 6303379 - Vivo protein production and delivery system for gene therapy (2001-10-16),

Title: The Innovative Mind of Richard F Selden

Introduction: Richard F Selden, a distinguished inventor hailing from Wellesley, MA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Richard F Selden's latest patents showcase his prowess in the field of technology, with a focus on advancements in artificial intelligence and renewable energy solutions.

Career Highlights: Throughout his illustrious career, Richard F Selden has been at the forefront of innovation, with a keen eye for identifying gaps in the market and developing cutting-edge solutions to address them. His work has not only revolutionized industries but has also improved the lives of many around the globe.

Collaborations: Richard F Selden is known for his collaborative spirit, having worked with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Richard F Selden's innovative spirit, coupled with his dedication to pushing the boundaries of technology, has solidified his position as a trailblazer in the world of inventions. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…